Frontiers in Cancer Chemistry Research

Discover cutting-edge studies on carcinogenesis, biomarkers, and targeted therapeutic approaches

Research Articles

Awakening the Cell's Guardian: How a Novel PP2A Agonist Takes on Notorious KRAS-Driven Cancers

Discover how SMAPs (Small Molecule Activators of PP2A) can disarm KRAS by awakening the dormant tumor suppressor PP2A in KRAS-driven cancers.

Thomas Carter
Aug 10, 2025

Popular Articles

Research Tags